Butterfly Network (BFLY) Income from Continuing Operations (2020 - 2026)
Butterfly Network (BFLY) reported Income from Continuing Operations of 12677000.0 for Q1 2026, up 9.24% on a YoY basis from 11605142.49 in Q1 2025, and up 17.05% sequentially from 15282000.0 in Q4 2025.
Butterfly Network (BFLY) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Income from Continuing Operations data on file, last reported at 12677000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 9.24% year-over-year to 12677000.0; the trailing twelve-month figure through Mar 2026 stood at 75764000.0 (down 17.1% YoY), and the FY2025 full-year result was 77054000.0, down 6.29% from the prior year.
- Income from Continuing Operations advanced to 12677000.0 in Q1 2026, from 15282000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 12677000.0 in Q1 2026 to a low of 54742000.0 in Q3 2022.
- A 5-year average of 27332117.65 and a median of 27368000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations sank 6345.94% in 2022 and surged 58.97% in 2024, its largest moves.
- Tracing BFLY's Income from Continuing Operations over 5 years: stood at 33703000.0 in 2022, then slumped by 30.91% to 44119000.0 in 2023, then surged by 58.97% to 18103000.0 in 2024, then rose by 15.58% to 15282000.0 in 2025, then increased by 17.05% to 12677000.0 in 2026.
- Business Quant data shows BFLY's Income from Continuing Operations at 12677000.0 in Q1 2026, 15282000.0 in Q4 2025, and 33971000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Butterfly Network | 1.72 Bn | 1.58 Bn | 18.29 Mn | -12.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.68 Mn |
| Dec 31, 2025 | -15.28 Mn |
| Sep 30, 2025 | -33.97 Mn |
| Jun 30, 2025 | -13.83 Mn |
| Mar 31, 2025 | -13.97 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | -16.92 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -21.76 Mn |
| Dec 31, 2023 | -44.12 Mn |
| Sep 30, 2023 | -27.37 Mn |
| Jun 30, 2023 | -28.67 Mn |
| Mar 31, 2023 | -33.54 Mn |
| Dec 31, 2022 | -33.70 Mn |
| Sep 30, 2022 | -54.74 Mn |
| Jun 30, 2022 | -35.80 Mn |
| Mar 31, 2022 | -44.48 Mn |
| Dec 31, 2021 | -15.63 Mn |
| Sep 30, 2021 | -13.56 Mn |
| Jun 30, 2021 | -2.94 Mn |